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Genome-wide association studies (GWASs) are rapidly identi-fying loci affecting multiple social, behavioural and psychi-atric phenotypes1,2. Moreover, using cross-trait versions of 
methods such as genomic-relatedness-based restricted maximum 
likelihood (GREML)3 and linkage disequilibrium score regression 
(LDSC)4, researchers have identified genetic correlations between 
diverse traits; for example, age of first birth and risk of smoking5, 
insomnia and psychiatric traits (for example, schizophrenia)6, major 
depressive disorder (MDD) and number of children7, and educa-
tional attainment and cognitive performance8. Widespread statisti-
cal pleiotropy appears to be the rule rather than the exception across 
complex traits. Although these findings are currently suggestive of 
constellations of phenotypes affected by shared sources of genetic 
liability, existing methods do not permit the causes of the observed 
genetic correlations to be investigated systematically. Here, we intro-
duce genomic structural equation modelling (genomic SEM)—a 
new method for modelling the multivariate genetic architecture of 
constellations of traits and incorporating genetic covariance struc-
ture into multivariate GWAS discovery. Genomic SEM is a flexible 
framework for formally modelling the genetic covariance structure 
of complex traits using GWAS summary statistics from samples of 
varying and potentially unknown degrees of overlap, in contrast 
with existing methods that model phenotypic covariance structure9, 
with specific applications10, using raw data. Moreover, genomic SEM 
allows for the specification and comparison of a range of proposed 
multivariate genetic architectures, which improves on existing 
approaches for combining information across genetically correlated 
traits to aid in discovery11.
One powerful feature of genomic SEM is the capability to model 
shared genetic architecture across phenotypes with factors repre-
senting broad genetic liabilities, and compare the fit of different fac-
tor structures to the empirical data. When an appropriate model has 
been identified at the level of the genome-wide covariance struc-
ture, the researcher may incorporate individual single-nucleotide 
polymorphisms (SNPs) into the model to identify variants with 
effects on general dimensions of cross-trait liability, boost power for 
discovery, and calculate more valid and predictive polygenic scores 
(PGSs). Genomic SEM can also evaluate whether the multivariate 
genetic architecture implied by a specific model is applicable at the 
level of individual variants using developed estimates of heteroge-
neity. When certain SNPs only influence a subset of genetically cor-
related traits, a key assumption of other multivariate approaches is 
violated11. SNPs with high heterogeneity estimates can be flagged as 
likely to confer disproportionate liability towards individual traits, 
be removed when constructing polygenic risk scores, or be studied 
specifically to understand the nature of heterogeneity.
We validate key properties of genomic SEM with a series of simu-
lations, and illustrate the flexibility and utility of genomic SEM with 
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Genetic correlations estimated from genome-wide association studies (GWASs) reveal pervasive pleiotropy across a wide vari-
ety of phenotypes. We introduce genomic structural equation modelling (genomic SEM): a multivariate method for analysing 
the joint genetic architecture of complex traits. Genomic SEM synthesizes genetic correlations and single-nucleotide poly-
morphism heritabilities inferred from GWAS summary statistics of individual traits from samples with varying and unknown 
degrees of overlap. Genomic SEM can be used to model multivariate genetic associations among phenotypes, identify variants 
with effects on general dimensions of cross-trait liability, calculate more predictive polygenic scores and identify loci that cause 
divergence between traits. We demonstrate several applications of genomic SEM, including a joint analysis of summary statis-
tics from five psychiatric traits. We identify 27 independent single-nucleotide polymorphisms not previously identified in the 
contributing univariate GWASs. Polygenic scores from genomic SEM consistently outperform those from univariate GWASs. 
Genomic SEM is flexible and open ended, and allows for continuous innovation in multivariate genetic analysis.
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analyses of real data. These include a joint analysis of GWAS sum-
mary statistics from five genetically correlated psychiatric case-con-
trol traits: schizophrenia, bipolar disorder, MDD, post-traumatic 
stress disorder (PTSD) and anxiety. We model their joint genetic 
architecture using a general factor of psychopathology (p), for which 
we identify 27 independent SNPs not previously identified in the 
univariate GWASs, 5 of which can be validated based on separate 
GWASs. PGSs derived using this p factor consistently outperform 
PGSs derived from GWASs of the individual traits in out-of-sample 
prediction of psychiatric symptoms. Other demonstrations include 
a multivariate GWAS of neuroticism items, an exploratory factor 
analysis (EFA) of anthropometric traits and a simultaneous analysis 
of the unique genetic associations between schizophrenia, bipolar 
disorder and educational attainment.
Results
Genomic SEM is a two-stage structural equation modelling 
approach12–14. In stage 1, the empirical genetic covariance matrix 
and its associated sampling covariance matrix are estimated. The 
diagonal elements of the sampling covariance matrix are squared 
standard errors. The off-diagonal elements index the extent to 
which sampling errors of the estimates are associated, as may be 
the case when there is sample overlap across GWASs. In stage 2, a 
SEM is specified and parameters are estimated by minimizing the 
discrepancy between the model-implied genetic covariance matrix 
and the empirical covariance matrix obtained in the previous stage. 
We evaluate fit with the standardized root mean square resid-
ual (SRMR), model χ2, Akaike Information Criterion (AIC) and 
Comparative Fix Index (CFI; see Methods)13,15. In a set of simula-
tions, we verify key properties of genomic SEM (Methods). We find 
that genomic SEM produces unbiased parameter estimates when 
the correct structural model is specified, and that model fit indices 
consistently favour the correct model over alternative models. In a 
second set of simulations, we demonstrate that the inclusion of data 
from overlapping samples does not bias genomic SEM parameter 
estimates or their standard errors.
Genomic SEM can be employed as a tool for multivariate GWASs 
based on univariate summary statistics. First, the genetic covariance 
matrix and its associated sampling covariance matrix are expanded 
to include SNP effects. A genomic SEM is then specified in which 
SNP effects occur at the level of a latent genetic factor defined by 
several phenotypes, at the level of the genetic components of each 
of several (potentially genetically correlated) phenotypes, or some 
combination of the two. The genomic SEM is then run once per SNP 
(or each set of SNPs, should the user incorporate multiple SNPs into 
a model) to obtain its effects within the multivariate system.
We provide an index that quantifies the extent to which an 
observed vector of univariate regression effects of a given SNP on 
each of the phenotypes can be explained by a common pathway 
model that assumes that the effects are entirely mediated by the 
common genetic factor(s). In other words, the index enables the 
identification of loci that do and do not plausibly operate on the 
individual phenotypes exclusively by way of their associations with 
the common factor(s). Because of its intuitive and mathematical 
similarity to the meta-analytic Q statistic used in standard meta-
analyses to index heterogeneity of effect sizes16, we label this hetero-
geneity statistic QSNP. QSNP is a χ2-distributed test statistic, with larger 
values indexing a violation of the null hypothesis that the SNP acts 
entirely through the common factor(s).
Confirmatory factor analysis of genetic covariance matrices. We 
provide two examples of confirmatory factor analysis (CFA) using 
genomic SEM. In our first example, we fit a genetic factor model 
to psychiatric case-control traits. Recent findings indicate that the 
comorbidity across psychiatric disorders is captured by a general 
psychopathology factor (that is, the p factor), and this is widely 
supported based on previous results17–21. We tested for the pres-
ence of a single common genetic p factor using genomic SEM with 
European-only summary statistics for schizophrenia, bipolar disor-
der, MDD, PTSD and anxiety (Supplementary Table 1 for pheno-
types and sample sizes). The model fit was adequate (χ2(5) = 89.55; 
AIC = 109.50; CFI = 0.848; SRMR = 0.212). The results indicated 
that schizophrenia and bipolar disorder loaded the strongest onto 
the genetic p factor (Supplementary Fig. 1)—a pattern of findings 
that closely replicates previous findings from twin/family studies19.
In a second example, we tested for the presence of a single com-
mon genetic factor of neuroticism using summary statistics from 
12 item-level indicators from UK Biobank (UKB; Supplementary 
Table 1), as estimated using the Hail software22. The model fit 
was good (χ2(54) = 4,884.10; AIC = 4,932.11; CFI = 0.893; SRMR = 
0.109). The results indicated strong positive loadings for all indi-
cators (Supplementary Fig. 2). We used this single common factor 
model for both neuroticism and the p factor when estimating SNP 
effects for discovery under the section ‘SNP effects’ below.
EFA of a genetic covariance matrix. We provide two examples of 
how one might use exploratory methods to guide the specification 
of more nuanced factor models. In the first example, we submit-
ted the LDSC-derived genetic correlation matrix of the 12 neuroti-
cism items in UKB to EFA (see Supplementary Results). Based on 
these initial EFA results, follow-up CFAs (Supplementary Fig. 3) 
were specified using genomic SEM (standardized loadings > 0.4 
were retained; Supplementary Table 2). The two-factor solution 
(χ2(53) = 2,758.18; AIC = 2,808.18; CFI = 0.940; SRMR = 0.077) 
and three-factor solution (χ2(51) = 1,879.31; AIC = 1,933.31; 
CFI = 0.959; SRMR = 0.057) both provided excellent fit to the data 
and exceeded the fit of the single, common factor model. Consistent 
with the superior model fit indices for the two- and three-factor 
solutions, only 28 and 20 of the 69 QSNP hits from the single com-
mon factor model (described in further detail in the ‘SNP effects’ 
section below) continued to surpass genome-wide significance for 
the two- and three-factor models, respectively (Supplementary 
Fig. 4 and Supplementary Table 3). In addition, a GWAS of all 
HapMap3 SNPs for the two- and three-factor models revealed that 
the average size of QSNP across all SNPs was largest for the common 
factor (χ2(1) = 1.68), followed by the two-factor (χ2(1) = 1.64) and 
three-factor models (χ2(1) = 1.51). Thus, heterogeneity indices of 
individual SNP effects in the GWAS data agree with model fit indi-
ces, with both favouring the three-factor model of neuroticism.
In the second example, EFA was applied to the LDSC-derived 
genetic correlation matrix for nine anthropometric traits from the 
Early Growth Genetics and Genetic Investigation of Anthropometric 
Traits consortia (Supplementary Table 4). EFA results indicated that 
2 factors explained 61% of the total genetic variance. Moreover, a 
heat map of the genetic correlation matrix suggests two primary 
factors that index overweight and early life-growth phenotypes 
(Supplementary Fig. 5). A follow-up CFA (Supplementary Fig. 6) 
within genomic SEM was specified based on the EFA parameter 
estimates (standardized loadings > 0.25 were retained). The CFA 
showed good fit to the data (χ2(25) = 12,994.71; AIC = 13,034.71; 
CFI = 0.962; SRMR = 0.092). The results indicated highly signifi-
cant loadings and a small genetic correlation (rg) between the two 
factors (rg = 0.10; s.e. = 0.03; P < 0.001). This indicates that early-life 
physical growth is modestly associated with later life obesity traits 
via genetic pathways.
Genetic multivariable regression (replicating genome-wide 
inferred statistics (GWIS)). Nieuwboer et al.23 used summary sta-
tistics for educational achievement24 and both schizophrenia and 
bipolar disorder25 to determine whether genetic correlations with 
educational achievement are driven by variation specific to either 
disorder. Educational achievement is genetically correlated with 
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schizophrenia (rg = 0.148; s.e. = 0.050; P = 0.003) and bipolar dis-
order (rg = 0.273; s.e. = 0.067; P < 0.001). Using the GWIS method, 
they found that the correlation of educational achievement with 
schizophrenia unique of bipolar is small (rg = 0.040; s.e. = 0.082; 
P = 0.627), whereas the genetic correlation between bipolar unique 
of schizophrenia and educational achievement is far less attenuated 
(rg = 0.218; s.e. = 0.102; P = 0.032). We used genomic SEM with the 
aim of replicating these results using a conceptually similar, but sta-
tistically distinct, framework. We present this example to demon-
strate that genomic SEM is not limited to factor analytical models, 
but can be used to construct and test an array of hypotheses using a 
general SEM approach.
Using the same univariate GWAS summary statistics employed 
in the original application of GWIS, we used genomic SEM to fit a 
structural multivariable regression model in which the genetic com-
ponent of educational achievement was simultaneously regressed 
onto the genetic components of schizophrenia and bipolar disorder. 
The results confirmed the findings of Nieuwboer et al.23; the condi-
tional standardized association between schizophrenia and educa-
tional achievement was small (bg = −0.016; s.e. = 0.096; P = 0.867), 
whereas there was a strong conditional standardized association 
between bipolar disorder and educational achievement (bg = 0.283; 
s.e. = 0.113; P = 0.012; Supplementary Fig. 7).
SNP effects. Common factor models. A powerful application of 
genomic SEM is to include individual SNP effects in both the 
genetic covariance matrix and the sampling covariance matrix, to 
estimate the effect of a given SNP on the latent genetic factor(s). 
If the summary statistics are composed of M different SNPs, 
M models are estimated to obtain genome-wide summary statis-
tics for the latent factor. As an example of genomic SEM used for 
multivariate GWAS, we incorporated SNP effects into the p-factor 
and neuroticism models presented above. Linkage disequilibrium-
independent hits are defined below using a clumping threshold 
of r2 < 0.1 in a 500-kilobase (kb) window, with the exception of 
a 1-megabase (Mb) window for chromosomes 6 and 8. A total of 
128 independent loci were genome-wide significant for the p factor 
(P < 5 × 10−8; Supplementary Figs. 8–10 and Figs. 1a and 2a). Of the 
128 loci, 27 independent loci were not previously identified in any 
of the contributing univariate GWASs (Table 1 and Supplementary 
Table 5). Of these 27 loci, 5 were identified as either genome-wide 
significant or suggestive of significance (P < 1 × 10−5) in a separate, 
previously published GWAS of 1 of the 5 traits. A total of 118 loci 
were genome-wide significant for neuroticism, with 38 loci not 
identified in the univariate item-level GWASs (Supplementary 
Table 6 and Figs. 1b and 2b). Plots of item-level effects for indi-
vidual SNPs revealed high consistency in magnitude and direction 
for SNPs identified as genome-wide significant for the common 
factors (Supplementary Fig. 11). Although there is early lift-off 
in the Q–Q plots for both common factors, LDSC analyses of the 
summary statistics produced by genomic SEM indicated that the 
results were not due to uncontrolled inflation for either the p factor 
(intercept = 0.987; s.e. = 0.014) or neuroticism (intercept = 0.997; 
s.e. = 0.001).
General trends. Mean χ2 statistics were higher for the genomic 
SEM-derived summary statistics of common factors relative to 
univariate indicators (Table 1). It is important to note here that, 
whereas genomic SEM may boost power in many cases, this is 
not the primary purpose of the method. Rather, it is to identify 
the relationship between SNPs and observed phenotypes as medi-
tated through a user-specified model and to concurrently evaluate 
the construct validity of said model. Inspecting the distribution 
of univariate P values for the newly identified SNPs for the gen-
eral factors indicated that these SNPs were generally character-
ized by relatively low P values, albeit not low enough to cross the 
genome-wide significance threshold for any individual phenotype 
(Supplementary Figs. 12 and 13).
QSNP results. The results revealed 1 and 69 independent QSNP 
loci for the p factor and neuroticism, respectively (Fig. 2c,d and 
Supplementary Fig. 14). For neuroticism, significant QSNP esti-
mates were obtained for SNPs that were highly significant for some 
traits but not others (Supplementary Table 7 and Supplementary 
Fig. 15). The association between P values for SNP effects and QSNP 
estimates were minimal (Supplementary Fig. 16). Comparing the 
QSNP estimates for SNPs identified as significant for only the p factor 
or neuroticism relative to SNPs identified as significant for one of 
the indicators, but not the common factor, indicated that the latter 
group of SNPs were characterized, as would be expected, by larger 
QSNP estimates (that is, greater heterogeneity in individual effects; 
Supplementary Fig. 17). Intercepts from LDSC analyses of the 
QSNP statistics also indicated that the results for the heterogeneity 
index were not attributable to inflation (p factor: intercept = 0.978; 
s.e. = 0.009; neuroticism: intercept = 0.963, s.e. = 0.009). Slopes from 
the same LDSC analyses further indicated genetic signal in hetero-
geneity (p factor: Z = 13.65; P = 6.68 × 10−42; neuroticism: Z = 30.23; 
P = 9.98 × 10−201).
Comparison with multi-trait analysis of GWAS (MTAG). Existing 
multivariate methods use summary statistics of genetically corre-
lated phenotypes to boost power for discovery and prediction for 
a particular trait11,26,27. Boosting power is only one application of 
genomic SEM. That said, a genomic SEM common factor GWAS 
approach has already been shown by an independent research 
group to perform comparably to existing multivariate approaches 
for out-of-sample prediction28. Moreover, as a flexible modelling 
framework, genomic SEM may encompass other multivariate 
approaches. For example, we show mathematically that genomic 
SEM can be specified to satisfy the same moment conditions as 
MTAG11 (see Supplementary Methods). Simulation results also 
revealed near-perfect correspondence from a linear regression in 
which Z statistics from MTAG were used to predict those from 
a genomic SEM specified to satisfy the MTAG moment condi-
tions (Supplementary Fig. 18; unstandardized slope = 0.999; inter-
cept = 2.65 × 10−4).
Performance in empirical data under controlled missingness. We con-
trast estimates obtained from the common factor model of neuroti-
cism described above with estimates for a GWAS with an imposed 
missing structure. We first transformed the binary scale neuroti-
cism items into a smaller number of quantitative scores. To do so, 
we created three parcels of neuroticism items consisting of four 
items each with scores ranging from 0–4, at which point it is appro-
priate to treat the parcel as continuous29. Parcels were constructed 
based on the same EFA results described above and mirrored the 
composition of the three-factor model, with the exception that the 
irritability item was included with parcel 2 so as to have an equal 
distribution of four items per parcel. Of the 300,000 participants, 
100,000 non-overlapping participants were removed from 2 of the 3 
parcels for missing data models. The best-powered results (indexed 
by mean χ2 values) were for genomic SEM of the individual neuroti-
cism items presented above, indicating that construction of compos-
ite indices via averaging, although convenient, removes multivariate 
information that can otherwise be retained with genomic SEM 
(Supplementary Table 8). Genomic SEM analyses that incorporated 
supplementary information from parcels containing imposed miss-
ing data consistently outperformed GWASs of individual parcels 
with complete data, and performed nearly as well as analyses of 
complete data across all three parcels. Thus, the inclusion of sum-
mary data from genetically correlated phenotypes in genomic SEM 
may boost power relative to GWASs of the individual phenotypes, 
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even when there is high sample overlap and sample sizes are uneven 
across phenotypes.
Parcel comparison of QSNP. Using the three constructed parcels 
without any missing data, the distribution of P values was compared 
across SNPs with high (P < 5 × 10−8) and low (P > 5 × 10−3) QSNP esti-
mates from the item-level genomic SEM analysis of neuroticism for 
SNPs that were genome-wide significant in at least one of the par-
cels. These results indicated that, for SNPs with a higher QSNP for the 
common factor, there was more discordance of effect sizes among 
three lower-order factors relative to SNPs that produced lower het-
erogeneity estimates (Supplementary Fig. 19). The average differ-
ences between the highest and lowest −log10[P] values were 10.56 
and 4.96 for high and low QSNP, respectively. This suggests that QSNP 
is appropriately indexing discordance in SNP-level effects across 
genetically correlated indicators.
Polygenic prediction. We re-estimated the p factor model using the 
summary statistics from the schizophrenia and MDD GWASs that 
did not overlap with the UKB dataset to predict psychiatric symp-
toms in UKB (see Supplementary Fig. 20 for the phenotypic model). 
To produce a reliable set of targets for polygenic prediction, and to 
focus our analyses on construct validation, latent factors of psy-
chiatric symptoms were specified as the out-of-sample targets. We 
compared the magnitude of out-of-sample prediction for the p fac-
tor PGSs predicting the phenotypic p factor and factors of individual 
psychiatric domains relative to the prediction using PGSs derived 
from univariate summary statistics (Fig. 3 and Supplementary 
Table 9). The PGS for the genetic p factor predicted more variance 
in symptoms of depression, psychotic experiences, mania, anxiety, 
PTSD and a phenotypic p factor than any univariate PGS.
For neuroticism, univariate PGSs were constructed in data 
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Fig. 1 | Genomic SEM solutions for p- and neuroticism-factor models with SNP effect. a,b, Standardized results from using genomic SEM (with WLS 
estimation) to construct a genetically defined p factor of psychopathology (a) and a genetic neuroticism factor (b) with a lead independent SNP predicting the 
factors (rs4552973 for the p factor and rs10497655 for neuroticism). Standard errors are shown in parentheses. For a model that was standardized with respect 
to the outcomes only, the effect of the SNP was −0.093 (s.e. = 0.017; SNP variance = 0.252) for the p factor and −0.042 (s.e. = 0.007; SNP variance = 0.432) for 
neuroticism. This can be interpreted as the expected standard deviation unit difference in the latent factor per effect allele. The subscript g is used in these path 
diagrams to denote genetic variables. The u variables reflect the residual variance in the genetic indicators not explained by the common factor. ANX, anxiety; 
BIP, bipolar disorder; Emb, worry too long after embarrassment; Fed-up, fed-up feelings; Feel, sensitivity/hurt feelings; Irr, irritability; SCZ, schizophrenia.
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the 12 neuroticism items, genomic SEM factor of items, 3 neuroti-
cism parcels, genomic SEM factor of parcels and neuroticism sum 
score. We used PGSs to predict a sum score composed of the same 
neuroticism items administered in UKB. We also calculated mean 
χ2 values for each of these summary statistics, which we used to 
infer their relative power. Of all of the summary statistics consid-
ered, summary statistics derived from a genomic SEM analysis of 
a common factor of the neuroticism items produced the largest 
mean χ2 in the summary statistics and predicted the greatest vari-
ance in the out-of-sample phenotype (Supplementary Fig. 21). In 
both cases, the superior performance of genomic SEM analysis of 
the common factor of items relative to the sum score of the items 
is probably, in part, a reflection of the fact that the sum score in 
UKB was created using listwise deletion, resulting in a reduced 
sample size of 274,008. Conversely, genomic SEM uses all avail-
able information from neuroticism items, with sample sizes of 
~325,000 each. In more severe cases of sample non-overlap, we 
would expect even larger power benefits of genomic SEM-derived 
summary statistics relative to individual items or sum scores. 
Indeed, in instances of minimal sample overlap, it is not possible 
to compute sum scores, but genomic SEM can still be used to inte-
grate data across phenotypes.
Biological annotation. The biological function of the SNPs related 
to the p factor and neuroticism was examined using DEPICT30. 
Table 1 presents the number of enriched gene sets, prioritized genes, 
and enriched tissues and cell types across the univariate statistics 
and common factors (see Supplementary Tables 10–18 for detailed 
output). Common factors produced more informative results than 
the individual indicators. As expected, all of the tissue enrich-
ment for the common factors was identified in the nervous system 
(Supplementary Fig. 22). Neuroticism-prioritized genes indicated a 
central role of synaptic activity (for example, STX1B, NR4A2 and 
PCLO), including glutamatergic neurotransmission (GRM3). The 
p factor gene sets were largely characterized by communication 
between neurons (for example, ‘dendrite development’, ‘dendritic 
spine’ and ‘abnormal excitatory postsynaptic potential’). Biological 
annotation of QSNP statistics for neuroticism indicated that genes 
within the 69 loci related to neuroticism, but not through a single 
factor, include: GRIA1, a glutamate receptor subunit (involved in 
signalling in excitatory neurons) that has previously been related 
to schizophrenia31, chronotype32 and autism33; and PCDH17, a gene 
involved in cellular connections in the brain that has been related 
to intelligence34.
General guidelines. When implementing genomic SEM, users 
should be aware of the limitations and assumptions of the method. 
First, because genomic SEM is a method for modelling genetic cova-
riance matrices, it relies on the same assumptions as the method 
used to estimate genetic covariances, and best practices for imple-
menting such a method should be followed. For example, when 
LDSC is used to construct the genetic covariance matrix, SNPs 
should not first be pruned for linkage disequilibrium, and sum-
mary statistics for different phenotypes should be obtained from 
ethnically homogeneous samples of similar ancestral backgrounds4. 
With respect to selecting between competing models, users should 
take into account a variety of both absolute fit indices (for example, 
SRMR and model χ2) and relative fit indices (for example, AIC and 
χ2 difference). We provide general standards for absolute model fit 
in the Methods. Finally, a formal power analysis should take into 
account specific characteristics of the summary data, genetic archi-
tecture of the phenotypes and model to be specified. This can typi-
cally be achieved with simulation. Generally speaking, we would 
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Fig. 2 | Manhattan plots of unique, independent hits from genomic SEM. a–d, Genomic SEM (with WLS estimation) was used to conduct multivariate 
GWASs of the p factor (a and c) and neuroticism (b and d). Manhattan plots are shown for SNP effects (a and b) and QSNP (c and d). The grey dashed line 
marks the threshold for genome-wide significance (P < 5 × 10−8). Black triangles denote independent hits for SNP effects from the GWAS of the general 
factor that were not in linkage disequilibrium with independent hits for the univariate GWAS or hits for QSNP. Purple diamonds denote independent hits 
for the SNP effects from univariate GWASs that were not in linkage disequilibrium with independent hits from the GWAS of the general factor. Grey stars 
denote independent hits for QSNP.
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to increase when the constituent univariate GWASs have larger 
sample sizes, higher heritabilities, higher genetic correlations with 
one another and lower sample overlap with one another. That said, 
we still expect some power benefits relative to univariate GWASs 
when the constituent phenotypes are only moderately heritable 
and/or moderately genetically correlated and/or sample overlap is 
high. The choice of included summary statistics, phenotypes and 
model(s) will of course depend on the researcher’s objectives and 
the model(s) to be specified.
Discussion
Applications of genome-wide methods to data from large-scale 
population-based samples have uncovered clear evidence of perva-
sive statistical pleiotropy. Genomic SEM is a method for modelling 
the multivariate genetic architecture of constellations of genetically 
correlated traits and incorporating genetic covariance structure 
into multivariate GWAS discovery. In contrast with methods9 that 
model phenotypic rather than genetic covariance structure, and 
rely on raw data, genomic SEM employs summary GWAS data to 
model genetic covariance structure. Genomic SEM is computation-
ally efficient, accounts for potentially unknown degrees of sample 
overlap and allows for flexible specification of covariance structure, 
such that several broad classes of structured covariance models can 
be applied. The genomic SEM approach shares benefits of some 
existing approaches11 for boosting power by combining informa-
tion across genetically correlated phenotypes. However, genomic 
SEM uniquely allows one to compare different hypothesized genetic 
covariance architectures and to incorporate such architectures into 
multivariate discovery. Importantly, shared genetic liabilities across 
phenotypes can be explicitly modelled as factors that may be treated 
as broad genetic risk factors with equally broad downstream conse-
quences. Multivariate genetic methods have existed for decades in 
the twin literature, with Martin and Eaves35 providing a framework 
for fitting structural equation models of genetic and environmental 
variance components to multivariate twin data. Using GWAS sum-
mary data from unrelated individuals, genomic SEM can be used to 
estimate multivariate genetic models similar to those from the exist-
ing twin literature. Moreover, genomic SEM offers new promise as 
a method that allows for modelling genetic covariance even among 
phenotypes for which phenotypic covariance cannot be estimated.
Genomic SEM is not the first method for multivariate GWAS. 
Other methods, such as MTAG11, SHom/SHet36, metaUSTAT37, 
min-P38 and TATES27 allow researchers to perform multivariate 
meta-analyses based solely on summary data. The methods can 
generally be divided into two distinct classes: methods that aggre-
gate test statistics or effect sizes based on a model (genomic SEM, 
SHom and MTAG) and those that select from the univariate P val-
ues while taking care not to inflate type-I error (min-P, TATES 
and SHet). As we show with respect to MTAG, models on which 
existing methods are based may can be fit within the genomic SEM 
framework. We also anticipate that the approaches for selecting the 
P values from a set of analyses while maintaining proper type-I error 
control could be integrated into the genomic SEM framework. For 
instance, whereas TATES is currently applied to select P values from 
Table 1 | Summary of multivariate (genomic SEM) and univariate GWAS results
Lead SNPs 
(P < 5 × 10−8)








Genomic SEM (WLS) 128 1 (1) 27 71 37 24 1.88
Schizophrenia 127 – 34 (0) 2 25 21 1.82
Bipolar 4 – 4 (0) 0 0 0 1.15
MDD 5 – 5 (0) 0 0 0 1.31
PTSD 0 – 0 (0) 0 0 0 1.01
Anxiety 1 – 1 (0) 0 0 0 1.03
Neuroticism
Genomic SEM (WLS) 118 69 (5) 38 1 19 20 1.64
Mood 43 – 19 (5) 0 0 15 1.37
Misery 31 – 6 (4) 0 0 0 1.32
Irritability 36 – 17 (4) 0 0 0 1.37
Hurt feelings 24 – 11 (0) 0 0 0 1.33
Fed-up 38 – 21 (6) 0 0 0 1.36
Nervous 41 – 25 (12) 0 0 0 1.36
Worry 56 – 26 (6) 0 13 0 1.46
Tense 19 – 10 (3) 0 0 0 1.32
Embarrass 17 – 6 (2) 0 0 0 1.33
Nerves 12 – 7 (3) 0 0 0 1.26
Lonely 6 – 4 (3) 0 0 0 1.19
Guilt 21 – 8 (1) 0 0 0 1.28
aNumbers in parentheses for QSNP report how many QSNP hits were in linkage disequilibrium with hits identified as significant for the common factor. bUnique hits for the common factor refers to lead 
SNPs that were not in linkage disequilibrium with hits for the individual indicators. Unique hits for the individual indicators refer to hits for the respective indicator that were not in linkage disequilibrium 
with hits for the common factor. Unique hits for the common factor excluded hits in linkage disequilibrium with QSNP hits. For unique hits for indicators, values in parentheses indicate whether any of 
these hits were identified as significant for QSNP. For unique hits for the common factor, hits were excluded that were in linkage disequilibrium with previously reported indicator hits that were removed 
due to missing values across the other phenotypes. The single QSNP hit for WLS estimation of the p factor was significant for both the common factor and schizophrenia. For the common factor and the 
indicators, independent hits were defined using a pruning window of 500 kb and r2 > 0.1. For chromosomes 6 and 8, an additional pruning filter of 1 Mb and r2 > 0.1 was used to account for long-range 
linkage disequilibrium due to the MHC region and pericentric inversion, respectively. For univariate statistics, we used only the SNPs present across all indicators to facilitate a direct comparison with 
genomic SEM results.
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a series of univariate analyses of correlated traits, the same analy-
sis could be used to select P values from a series of genomic SEM 
models. The multivariate methods available need not be mutually 
exclusive. With respect to other multivariate analyses of genome-
wide data that go beyond multivariate GWAS discovery, the major 
alternatives to genomic SEM that we are aware of are GWIS23 and 
GW-SEM9. When considering linear relationships between traits, 
genomic SEM is more flexible and user friendly than GWIS, and 
GW-SEM requires access to phenotypic data, which is a substantial 
limitation for many applications.
Unlike approaches that assume homogeneity of effects across 
SNPs11, genomic SEM includes diagnostic indices for its key assump-
tions, including a test for heterogeneity, QSNP, that can be applied 
at the level of the individual SNPs. This offers the unique ability 
to identify SNPs that confer specific risk to individual phenotypes. 
This question may be of particular interest as the large degrees of 
genetic overlap identified across phenotypes (for example, bipolar 
disorder and schizophrenia) beg the question: what are the genetic 
causes of phenotypic divergence? Whereas previous GWASs have 
combined items tapping genetically related phenotypes into a single 
score, or even combined cases with different diagnoses to obtain 
a shared genetic effect, genomic SEM allows researchers to inter-
rogate shared genetic effects between diagnoses or indicators, while 
concurrently testing for causes of divergence (that is, loci that are 
related only to a specific phenotype, or subset of phenotypes, but 
not the more general liability). In the context of neuroticism, for 
example, we identified 69 loci that were significantly involved in 
one manifestation of neuroticism but whose effects were not shared 
through a common factor, offering novel evidence of biological het-
erogeneity in the aetiology of a construct long thought to be unidi-
mensional. Because genomic SEM relies only on GWAS summary 
data, it can be applied to a broad spectrum of traits, including social, 
economic, cognitive and psychiatric outcomes.
Methods
Overview of genomic SEM. Genomic SEM is a two-stage structural equation 
modelling approach12–14. In the first stage, the empirical genetic covariance matrix 
and its sampling covariance matrix are estimated. In principle, these matrices may 
be obtained using a variety of methods for estimating SNP heritabilities, genetic 
covariances and their joint estimation errors. Here, we use a novel version of LDSC 
that accounts for potentially unknown degrees of sample overlap by populating 
the off-diagonal elements of the sampling covariance matrix. The same strengths, 
as well as assumptions and limitations, that are known to apply to LDSC39,40 apply 
to its extension used here and to genomic SEM. In stage 2, the user specifies a 
multivariate system of regression and covariance associations involving the genetic 
components of phenotypes with one another and/or more general latent factors. 
These associations are represented by parameters that may be fixed or freely 
estimated, as long as the model is statistically identified (for example, the number 
of freely estimated parameters does not exceed the number of non-redundant 
elements in the genetic covariance matrix being modelled). A set of parameters 
(θ) is estimated such that the fit function indexing the discrepancy between the 
model-implied covariance matrix, ∑(θ), and the empirical covariance matrix, S, 
estimated in stage 1 is minimized. Model fit is considered good when ∑(θ) closely 
approximates S. In the main text, we highlight the results from weighted least 
squares (WLS) estimation that weights the discrepancy function using the inverse 
of the diagonal elements of the sampling covariance matrix, and produces model 
standard errors using the full sampling covariance matrix. In the Supplementary 
Results, we additionally report the results from an alternative normal theory 
maximum likelihood estimation method.
Form of structured covariance models. Genomic SEM provides substantial 
user flexibility with respect to the particular SEM that is specified to produce 
the model-implied covariance matrix ∑(θ) that approximates the empirical 
covariance matrix, S. SEMs can be partitioned into two sets of equations—one 
describing the measurement model and the other describing the structural model. 
In the measurement model, the genetic components of k ‘indicator’ phenotypes 
are described as linear functions of a smaller set of m (continuous) latent 
variables, Λη ε= +y . In this equation, y is a k × 1 vector of indicators, ε is a k × 1 
vector of residuals, η is an m × 1 vector of latent variables and Λ is a k × m matrix 
of factor loadings (that is, regressions relating the latent variables to the set of 
indicators). In a typical application of genomic SEM, each indicator is a function 
of exactly one of the latent variables (although this so-called ‘simple structure’ 
restriction may be relaxed). In a CFA model, only the measurement model is 
specified, and the set of latent variables are allowed to freely co-vary. Thus, the 
model-implied covariance matrix of a CFA is Σ(θ) = ΛΨΛ′ + Θ, where Ψ is an 
m × m latent variable covariance matrix and Θ is a k × k matrix of covariances 
among the residuals, ε. Typically, Θ is diagonal, which implies that indicators are 
mutually independent conditional on the set of latent variables. That constraint 
may be relaxed such that select pairs of indicators are allowed to co-vary over 
and above their associations via the latent variable structure (that is, residual 
covariances are allowed). CFA models are typically used to assess the strength 
of relations between sets of indicators and their respective underlying latent 
variables, as well as to assess the fit of a measurement model to data. A well-fitting 
CFA model implies that the latent variable structure is able to account for the 
observed covariances among a set of indicator variables.
When a theory aims to explain associations among latent variables, a structural 
model can be added to the measurement model to produce a full SEM. The 
structural model of a SEM relates latent variables to each other via directed 
regression coefficients. It can be written in matrix notation as η = Bη + ζ, where 
B is an m × m matrix of regression coefficients that relate latent variables to each 
other, and ζ is an m × 1 vector of latent variable residuals. The model-implied 
covariance matrix of observed variables is Σ(θ) = Λ(I − B)−1Ψ[(I − B)−1]´Λ′ + Θ, 
where I is an k × k identity matrix41. Thus, in a full SEM, the empirical matrix is 
represented by a set of parameters that relate observed variables to latent variables, 
and latent variables to each other in a series of linear equations.
Path diagrams. SEMs can be represented graphically as path diagrams 
representing regression and covariance relations among variables42. In path 
diagrams, observed variables are represented as squares and unobserved (that 
is, latent) variables are represented as circles. Regression relationships between 
variables are represented as one-headed arrows pointing from the independent 
variable to the dependent variable. Covariance relationships between variables 
are represented as two-headed arrows linking the two variables. The variance of 
a variable (that is, the covariance between a variable and itself) is represented 
as a two-headed arrow connecting the variable to itself. In genomic SEM, we 
represent the genetic component of each phenotype with a circle, as the genetic 
component is a latent variable that is not directly measured, but is inferred from 
LDSC (it is the phenotype itself that is observed in the raw data that is used to 
produce the summary statistics). SNPs are directly measured, and are therefore 
represented as squares. When all elements in a SEM are represented in a path 
diagram, the diagram contains the full system of algebraic equations needed to 












































Fig. 3 | out-of-sample prediction using genomic SEM- and univariate-
based PGSs for psychiatric traits. PGSs were constructed using the same 
set of SNPs for all predictors. R2 on the y axis indicates the percentage 
of variance (possible range: 0–100) explained in the outcome unique of 
covariates. The summary statistics for genomic SEM were estimated using 
WLS. The genomic SEM-based PGS was derived from a model estimating 
SNP effects on a common p factor, constructed from schizophrenia, bipolar, 
MDD, PTSD and anxiety (as in Fig. 1a). To prevent bias, the genomic SEM 
summary statistics were produced using schizophrenia and MDD GWAS 
summary statistics that did not include UKB participants. Error bars indicate 
95% confidence intervals estimated using the delta method. Phenotypes 
were constructed for European participants in the UKB for five symptom 
domains and for a general p factor spanning all five symptom domains.
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Stage 1 estimation. In stage 1, the empirical genetic covariance matrix (SLDSC) 
and its associated sampling covariance matrix (VSLDSC) are estimated using our 
multivariable extension of LDSC. SLDSC is a k × k symmetric matrix with SNP 
heritabilities on the diagonal and genetic covariances (σgi,gj) between phenotypes 
i and j off the diagonal. The genetic covariance between phenotypes i and j 
can be computed as the genetic correlation scaled relative to the total genetic 
variance of each of the two contributing phenotypes (themselves scaled to unit 
variances), σ = ⋅ ⋅r h hi j i j i jg ,g g ,g
2 2 . Thus, the genetic covariance matrix of order k has 





































To produce unbiased standard error estimates and test statistics, we require the 
sampling covariance matrix, VSLDSC, of the LDSC estimates that is composed of all 
non-redundant elements in the SLDSC matrix. Thus, it is a symmetric matrix of order 
k*, with k*(k* + 1)/2 non-redundant elements. The diagonal elements of VSLDSC are 
sampling variances (that is, squared standard errors of the elements in SLDSC). The 
off-diagonal elements of VSLDSC are sampling covariances that indicate the extent  
to which the sampling distributions of the variance and covariance estimates in 
SLDSC co-vary with one another, as would be expected when there is overlap  
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The diagonal elements of VSLDSC can be estimated using the jackknife 
resampling procedure in the bivariate version of LDSC that is currently 
available from its original developers4,43. The LDSC function introduced in 
the GenomicSEM software package expands the jackknife procedure to the 
multivariable context to additionally produce sampling covariances (which index 
dependencies among estimation errors) among the elements of SLDSC needed to 
populate the off-diagonal elements of VSLDSC .
Incorporating individual SNP effects. Several steps are needed to incorporate 
individual SNP effects into genomic SEM. The first step requires that the inputted 
genetic covariance matrix be expanded to include covariances between the SNP 
and each of the phenotypes, g1 through gk, by appending a vector of SNP phenotype 
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The sampling covariance matrix, VSFull, associated with this expanded SFull 
covariance matrix, includes a number of components. One block of this VSFull 
matrix, VSLDSC, contains the sampling variances and sampling covariances of the 
latent genetic variances (SNP heritabilities) and genetic covariances, which are 
obtained from the multivariable LDSC approach introduced above. A second block 
of the VSFull matrix, VSSNP, is composed of the sampling covariance matrix of the 
SNP effects on the phenotypes. The SNP variance (derived from reference panel 
data) is treated as fixed, and its sampling variance and sampling covariance with 
all other terms are fixed to 0 (or to a very small value to facilitate computational 
tractability). The sampling covariances of the SNP genotype covariances with 
one another are obtained using cross-trait LDSC intercepts (which represent 
sampling correlations weighted by sample overlap) after being rescaled relative 
to the sampling variances of the respective SNP genotype covariances11,44. A final 
block of the VSFull matrix represents the sampling covariance of the SNP genotype 
covariances with the genetic variances and genetic covariances. These are fixed 
to 0, as sampling variation of the SNP genotype covariance is expected to be 
independent of the test statistics of all linkage disequilibrium blocks except the 
one it occupies. Because the sampling variance of the heritabilities and genetic 
correlations derive from sampling variability in the test statistics within all of the 
linkage disequilibrium blocks, their sampling covariances with a single SNP effect 



















Stage 2 estimation. In stage 2, the genetic covariance matrix obtained in the 
previous stage, S, is used to estimate the parameters in a SEM. In this stage, we 
allow for both WLS and normal theory maximum likelihood estimators. WLS 
does not strictly require positive definite S and VS matrices, but may still benefit 
from positive definiteness during optimization. Maximum likelihood estimation 
requires both S and VS to be positive definite. The GenomicSEM software package 
therefore smooths S and VS to the nearest positive definite matrices before stage 2 
estimation using the R function nearPD45.
The fit function minimized in the diagonally weighted version of WLS 
estimation that is standard in the GenomicSEM software package is the following:
θ σ θ σ θ= − ′ −−F s D s( ) ( ( )) ( ( ))SWLS
1
where S and Σ(θ) have been half-vectorized to produce s and σ(θ), respectively, 
and DS is VS with its off-diagonal elements set to 0. We choose the diagonally 
weighted version of WLS because it is more tractable to implement for large 
(highly multivariate) matrices and is more stable than fully weighted WLS in finite 
samples46,47.
Maximum likelihood estimation proceeds by minimizing the following fit 
function:
θ Σ θ Σ θ= ∣ ∣− ∣ ∣ + −−F S tr S k( ) log ( ) log { ( )}ML
1
where Σ θ( )  is the covariance matrix implied by the set of parameter estimates. 
Note that, while the formulation of the maximum likelihood fit function 
does not explicitly include a weight matrix, it is asymptotically equivalent 
to a more general formulation that is identical to the WLS fit function, with 
Σ θ Σ θ. ′ ⊗− −D D5 ( ( ) ( ))k k
1 1 , where Dk is the duplication matrix of order k, in place 
of DS. Thus, the difference between maximum likelihood and WLS estimation 
can be construed as a difference in weight matrices only. A comparison between 
maximum likelihood and WLS results can be found in the Supplementary Results 
(see also Supplementary Figs. 23–27 and Supplementary Table 19).
WLS estimation more heavily prioritizes reducing misfit in those cells in the S 
matrix that are estimated with greater precision. This has the desirable property of 
potentially decreasing sampling variance of the genomic SEM parameter estimates, 
which may boost power for SNP discovery and increase polygenic prediction. 
However, because the precision of cells in the S matrix is contingent on the sample 
sizes for the contributing univariate GWASs, WLS may produce a solution that 
is dominated by the patterns of association involving the most well-powered 
GWASs, and contain substantial local misfit in cells of S that are informed by 
lower-powered GWASs. In other words, WLS relative to maximum likelihood may 
more heavily prioritize minimizing sampling variance of the parameter estimates 
in the so-called variance bias tradeoff48. We expect that this will only occur when 
the model is overidentified (that is, d.f. > 0), such that exact fit cannot be obtained, 
and that divergence in WLS and maximum likelihood estimates will be most 
pronounced when there is lower sample overlap and the contributing univariate 
GWASs differ substantially in power. Maximum likelihood estimation may be 
preferred when the goal is to most evenly weight the contribution of the univariate 
sample statistics.
Both WLS and maximum likelihood fit functions will produce consistent 
estimates of the model parameters when the model is true47. However, the ‘naive’ 
standard errors and fit statistic produced in stage 2 estimation will be incorrect, 
because neither estimator uses the full VS matrix in estimation. Thus, robust 
corrections must be applied to produce consistent estimates of standard errors and 
test statistics. The correct sampling covariance matrix of the stage 2, genomic SEM 
parameter estimates (that is, Vθ) can be obtained using a sandwich correction13,47:
Δ Γ Δ Δ Γ Γ Δ Δ Γ Δ= ̂′ ̂ ̂ ′ ̂ ̂ ′ ̂θ
− − − − − −V V( ) ( )S
1 1 1 1 1 1





( )  is the matrix of model derivatives evaluated at the parameter 
estimates, Γ is the naive stage 2 weight matrix that takes its form depending on the 
estimation method used (WLS or maximum likelihood), and VS is the sampling 
covariance matrix of S obtained using multivariable LDSC.
It may not always be possible to obtain the full sampling covariance matrix, VS. 
For example, for highly sensitive data, only the matrix S and the standard errors 
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of its elements may be available (that is, the diagonal of VS). However, we note 
that when there is low sample overlap across the GWASs for each phenotype, off-
diagonal elements of the sampling covariance matrix are small and pragmatically 
ignorable. Moreover, in other contexts with complete sample overlap, standard 
error inflation of the SEM parameters estimated using diagonally weighted versions 
of WLS has been estimated to be less than 8%9 without robustness corrections, and 
0% with robustness corrections47.
Standardization and scaling of summary statistics for multivariate GWASs. 
Typically, GWAS summary statistics for quantitative phenotypes are not reported 
in terms of covariances, but are reported as ordinary least squared (OLS) 
unstandardized regression coefficients, with the phenotypes standardized before 
analyses (that is, the coefficients are standardized with respect to the outcome, but 
not the predictor). To transform the partially standardized regression coefficient 
(bSNP,P) of a SNP effect on phenotype P to a covariance, we multiply by the variance 
of scores on the SNP. The variance (σSNP
2 ) of scores (0, 1, 2) of a biallelic autosomal 
SNP is estimated as 2pq, assuming Hardy–Weinberg equilibrium, where p is the 
minor allele frequency (MAF) and q = 1 − MAF, with the MAF typically obtained 
from a reference sample. As the latent genetic factors estimated in LDSC are scaled 
relative to unit-variance-scaled phenotypes (by virtue of the SNP heritability 
estimates being placed on the diagonal of S), no further scaling is needed to 
transform this SNP phenotype covariance into a SNP genotype covariance.
When OLS regression coefficients and standard errors are provided from an 
analysis in which the phenotype has not been standardized before analyses, or only 
Z statistics or P values (for which Z statistics can be readily obtained) are provided, 
the partially standardized regression coefficients and their standard errors can 
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is equal to the regression coefficient for the OLS GWAS of the unstandardized 
phenotype. These derived partially standardized coefficients are then transformed 
into covariances by multiplying by the variance of scores on the SNP, as above.
When the GWAS summary statistics are reported for logistic regressions 
of liabilities for categorical outcomes (for example, case/control status) on the 
SNP, the logistic regression coefficients can be transformed into covariances as 
above, by multiplying by the SNP variances. However, it is appropriate to further 
transform the coefficients and their standard errors such that they are scaled 
relative to unit-variance-scaled liability. This can be achieved by dividing by 










. If GWAS summary statistics are reported for odds ratios, they can be 
transformed to logistic regression coefficients by taking their natural logarithm. 
Standard errors for the logistic regression coefficient are obtained as s.e.OR/OR, 
where OR is the odds ratio. The derived logistic coefficients and their standard 
errors should further be transformed such that they are scaled relative to unit-
variance-scaled phenotypes, as above. Note that when the outcomes are categorical, 
the liability scale heritabilities and genetic covariances from multivariable LDSC 
(and not what are referred to as the ‘observed scale’ heritabilities and genetic 
covariances) should be used to populate the S matrix. This has the desirable 
property of both modelling the continuous scale of risk in the population and 
providing estimates that are independent of the observed prevalence of the 
categorical outcomes.
On occasion, summary statistics will be provided from OLS GWASs of 
categorical outcomes (for example, case/control status). Such an analysis is 
sometimes referred to as a linear probability model, as it (incorrectly) assumes 
that the association between the predictor and the probability of being in the 
comparison (for example, case) group relative to the reference (for example, 
control) group is linear. Parameters from the linear probability model are 
dependent not only on the strength of the association between the SNP and 
the continuous underlying liability, but also on the MAF and the proportion of 
comparison group members (cases) in the sample. Thus, parameters from the 
linear probability model cannot be used directly in genomic SEM. However, 
particularly in the case of complex traits, for which the effect sizes for individual 
SNPs are small, results from the linear probability model can be used to very 
closely approximate logistic regression coefficients and standard errors that are 
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 is 
equal to the regression coefficient from the linear probability model, blogit* PSNP,  
is the expected logistic regression coefficient that is derived from the linear 
probability model results, v is equal to the proportion of cases in the sample, and 
σSNP
2  is the variance of the SNP, computed from its MAF obtained from a reference 
sample, as above. To scale the derived logistic coefficient such that it is scaled 
relative to unit-variance-scaled liability, the coefficient should be divided by 






. Lloyd-Jones et al.49 report that in a real data analysis 
of UKB data, the exponentiated regression coefficient (that is, the odds ratio) 
obtained directly from a logistic regression-based GWAS and that derived from 
the linear probability model-based GWAS was nearly perfect (R2 > 98%; slope: ~1). 
We have verified this nearly perfect correspondence in our own simulations 
(Supplementary Fig. 28).
Even within samples of the same ethnicity, there are likely to be discrepancies 
between the MAFs of a reference sample and the sample that GWAS summary 
statistics were generated from. However, some summary statistics may not 
include allele frequencies, and using the same reference panel for standardization 
across phenotypes has the desirable property of maintaining consistency across 
summary statistics. To examine the effect of this decision, the betas for 30,000 
randomly selected SNPs for the mood phenotype from UKB were standardized 
using either the sample or reference panel MAF. The correlation between the 
betas was 0.982, and a linear regression of betas, standardized using reference 
panel MAF, predicting standardization using sample MAFs, revealed near-perfect 
correspondence (slope = 1.044; intercept = −6.54 × 10−6; Supplementary Fig. 29).
Model fit statistics. Model χ2 is an index of the exact fit of a SEM. It indexes 
whether the model-implied genetic covariance matrix, Σ(θ), differs from the 
empirical genetic covariance matrix, S. Model χ2 can also be used as a relative fit 
index for comparing nested models. Conventional SEM approaches to indexing 
model χ2 are based on formulas that directly incorporate sample size (N). Because 
there is not an N that directly corresponds to the genetic covariance matrix that 
is modelled by genomic SEM in the same way that N typically corresponds to an 
observed covariance matrix, we derived a formula for estimating model χ2 that 
does not require N, but instead incorporates the sampling covariance matrix of 
the model residuals. This is done in two steps. In step 1, the proposed model (for 
example, a common factor model) is estimated. In step 2, all of the step 1 estimates 
are fixed, and the residual covariances and residual variances of the indicators  
are freely estimated. Residual variances are estimated in step 2 by estimating  
the variances of k residual factors defined by the indicators. This provides an 
estimate of the discrepancy between the model-implied and observed covariance 
matrices, R = S − Σ(θ), along with the sampling covariance matrix (VR) of R.  
While the discrepancy between model-implied and observed covariance matrices 
can be computed simply by deriving covariance expectations from the step 1  
model and subtracting the observed covariance matrix, such an approach 
would not provide the corresponding VR matrix necessary for the calculations 
below. The VR matrix is expected to be positive semidefinite and, consequently, 
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where P1 is a matrix of principal components (eigenvectors) of VR, and E is a 
corresponding diagonal matrix consisting of non-zero eigenvalues. P0 reflects  
the null space of VR. Projecting Ri—a vector of residual covariances estimated  












This equation produces a test statistic that is χ2 distributed with degrees 
of freedom (r) equal to the difference between the number of non-redundant 
elements (k*) in the empirical covariance matrix (S) and the number of freely 
estimated parameters in the proposed model.
The CFI is a test of approximate model fit. CFI indexes the extent to which the 
proposed model fits better than a model that allows all phenotypes to be heritable, 
but assumes that they are genetically uncorrelated. The χ2 statistic can be used 
to calculate CFI by calculating a second χ2 statistic for a so-called independence 
model (that is, a model that estimates genetic variances of all phenotypes but 
assumes all genetic covariances to be zero, such that ∑(θ) is diagonal). CFI is 
calculated using the formula below50, with f = χ2 – d.f.:
−f f
f
(independence model) (proposed model)
(independence model)
For the χ2 value of the independence model, a model is estimated in step 1 
that includes only the variance of the indicators and no common factor. In step 2, 
these variances are fixed and the covariances among the indicators and variances 
of k residual factors defined by the indicators are estimated and used to populate 
the same equation above used to calculate the proposed model χ2. CFI values 
theoretically range from 0 to 1, with higher values indicating good fit. CFI values 
of ≥0.90 are typically considered acceptable fit, and values of ≥0.95 are typically 
considered good model fit51. When the empirical covariance matrix contains a 
large number of cells that are very close to 0, CFI values may be low, even when 
such cells are approximated well by the model.
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AIC is a relative fit index that balances fit with parsimony, and can be used to 
compare models regardless of whether they are nested. AIC is calculated as:
χ= + × fpAIC 22
where fp is the number of free parameters in the model52. Lower AIC values are 
considered superior.
SRMR is an index of approximate model fit that is calculated as the 
standardized root mean squared difference between the model-implied and 
observed correlations in Σ(θ) and S, respectively53. Higher SRMR values indicate 
a larger discrepancy between Σ(θ) and S. It is positively biased, with larger bias 
resulting when the contributing univariate GWAS samples are lower powered. 
SRMR values below 0.10 indicate acceptable fit, values less than 0.05 indicate good 
fit, and a value of 0 indicates perfect fit54.
We recommend that model-fit indices be considered concurrently, as 
individual indices each have their own strengths and limitations. Model χ2 
is an index of exact fit, with lower values indicating better fit. Model χ2 may 
oftentimes be statistically significant, indicating that the model-implied genetic 
covariance matrix significantly differs from the empirical (unrestricted) genetic 
covariance matrix, even when the model-implied covariance matrix very closely 
approximates the empirical genetic covariance matrix. Oftentimes, models that 
closely (albeit imperfectly) approximate the empirical genetic covariance matrix 
may be scientifically and inferentially useful. We thus recommend considering 
CFI and SRMR indices of absolute fit, even when model χ2 is significant. We also 
recommend using indices of relative fit to compare competing models of the same 
data (that is, different models fit to genetic covariance matrices derived from 
the exact same summary data for the exact same phenotypes). When models are 
nested, their respective χ2 values can be subtracted from one another to calculate a 
χ2 difference test, with d.f. equal to the difference in d.f. between the two models. 
This χ2 difference test indexes the extent to which the less complex model (that is, 
the model with more d.f.) approximates the empirical genetic covariance matrix 
significantly worse than the more complex model (that is, the model with fewer 
d.f.). If the χ2 difference test is significant, the more complex model should be 
chosen. If the χ2 difference test is not significant, the less complex model should 
be chosen, as it is more parsimonious and approximates the empirical genetic 
covariance matrix no worse than the more complex model. Two models are 
nested when the set of possible model-implied covariance matrices from one 
model is a subset of the set of possible model-implied covariance matrices of the 
second model55. Nesting can typically be confirmed if the less restrictive model 
can be derived from the more restrictive model by dropping or fixing parameters. 
Regardless of whether models are nested, they can be compared on CFI, SRMR and 
AIC, so long as the same data are being modelled.
QSNP test of heterogeneity. As with the computation of model χ2 outlined above, 
QSNP is calculated using a two-step procedure. In step 1, a common pathway model 
is fit in which both factor loadings, the SNP effect on the common factor(s) and 
the residual variances of the common and unique factors are freely estimated 
(with one factor loading fixed to unity for factor identification and scaling). No 
paths representing direct effects of the SNP on the genetic components of the 
individual phenotypes are estimated. In step 2, a common plus independent 
pathways model is specified, in which the factor loadings and the SNP effect on 
the common factor are fixed to the values estimated in step 1, and direct effects of 
the SNP on individual indicators and the residual variances of each indicator are 
freely estimated. Supplementary Fig. 30 depicts this model, as applied to a single 
common factor model, with parameters that are fixed in step 2 depicted in red and 
those that are freely estimated in step 2 depicted in black.
Genomic SEM simulations. Validation of summary-based model fit statistics via 
simulation. A generating population with a common factor model defined by  
4, 5 or 6 indicators was used to examine the null distribution of the newly derived 
χ2 test statistic using a set of 1,000 simulations per model. These simulations did 
not include individual genotypes, and were simulated solely based on a generating 
factor structure. For the 6-indicator models, the standardized factor loadings in 
the generating population were 0.42, 0.64, 0.22, 0.59, 0.19 and 0.64. The four- and 
five-indicator models specified the same factor loadings, excluding the last, or 
last two loadings, respectively. The results indicated that the two-step procedure 
described above produced a test statistic equivalent to the χ2 statistic calculated by 
lavaan from the raw data (Supplementary Fig. 31 and Supplementary Table 20). For a 
χ2-distributed test statistic, the mean of the null sampling distribution should match 
the d.f. of the test. As expected, the distribution of the test statistic conformed to a χ2 
distribution with an average approaching the d.f. (Supplementary Fig. 32). Calculated 
CFI values were also highly consistent with those observed using the CFI statistic 
provided by lavaan when using raw data (Supplementary Fig. 33 and Supplementary 
Table 20). Calculated AIC values were not contrasted with those obtained using the 
lavaan package in R in the simulations below, as the software uses a formula that 
includes a log-likelihood estimate contingent on the provided sample size.
Null distribution of QSNP. To verify that the null distribution for QSNP is χ2 
distributed, a set of simulations specified a generating population in which the 
direct effects of the SNP on the indicators were entirely mediated through the 
common factor. Each simulation included 1,000 datasets, with N = 100,000 
completely overlapping participants per dataset. All simulated datasets were 
analysed using both WLS and maximum likelihood. We examined 3 models 
with F = 1 factor and k = 4, 5 or 6 phenotypes. Supplementary Table 21 presents 
descriptive statistics for QSNP. Using a genome-wide significance threshold, in all 
cases, the false discovery rate for QSNP was 0, and the power to detect a SNP effect 
on the common factor was 1. Both WLS and maximum likelihood estimation 
produced mean estimates of QSNP that were approximately equal to the d.f. of 
the corresponding model. Supplementary Fig. 34 depicts the null sampling 
distributions of QSNP estimated using WLS or maximum likelihood. Supplementary 
Fig. 35 plots QSNP from these two estimation methods against χ2 distributions and 
against one another. These results indicate that both estimation methods produce 
results that are approximately χ2 distributed.
Simulation of factor structure. To evaluate the ability of genomic SEM to capture 
the genetic factor structure in the generating population, the GCTA package3 was 
used to generate 100 sets of 6 independent, 100% heritable phenotypes (‘orthogonal 
genotypes’) to pair with genotypic data for 39,909 randomly selected, unrelated 
individuals of European descent from UKB data for the 1,209,498 SNPs present 
in HapMap3. The generating list of causal SNPs was set to 10,000 for all 600 
genotypes, with the specific list of causal variants sampled with replacement from 
the 1,209,498 SNPs. One of the six orthogonal genotypes per set was designated 
an index of the general genetic factor, and the remaining five were designated 
indices of domain-specific genetic factors. All of these orthogonal genotypes were 
scaled to M = 0 and s.d. = 1. Five new correlated genotypes were then constructed, 
each as the weighted linear combination of the general genetic factor and one 
domain-specific genetic factor. Weights for the contribution of the general genetic 
factor were λ F kg,  = 0.70, 0.60, 0.50, 0.40 and 0.30 for correlated genotypes 1–5, 




were then each constructed as the weighted linear combination of one of the 
correlated genotypes and domain-specific environmental factors (randomly 
sampled from a normal distribution with M = 0 and s.d. = 1). Heritabilities for 
phenotypes 1–5 were set to hk
2 = 35, 40, 50, 60 and 70%, respectively, such that 
the weights for the genotypes were hk
2  and the weights for the environmental 
factors were −h(1 )k
2 . We chose these figures to stabilize the properties of the 
distributions across simulations at 100 replications with N = ~39,000 each. We 
expect that with lower SNP h2 values, the same patterns would hold, albeit at larger 
sample sizes. Each of the 500 phenotypes (100 sets of 5 phenotypes) was then 
analysed as a univariate GWAS in PLINK56 to produce univariate GWAS summary 
statistics. Our multivariable LDSC function was then used to construct 100 sets of 
5 × 5 genetic covariance matrices (S) and associated sampling covariance matrices 
(VS), and genomic SEM was used to fit a 1-factor model to each set.
Usig this procedure, we performed 100 runs of genomic SEM on raw individual-
level genotype data for which we simulated multivariate phenotypic data to conform 
to a single genetic factor model (a latent trait that partially causes 5 observed 
outcomes). Across the 100 simulations, genomic SEM estimates closely matched the 
parameters specified in the generating population (Supplementary Fig. 36). Model 
standard errors also closely matched the standard deviations of parameter estimates. 
We also compared fit statistics (CFI, AIC and model χ2) for the correctly specified 
common factor model and two deliberately misspecified models: (1) a model in 
which all indicators were constrained to have the same factor loading; and (2) a 
model for which the loading of the third indicator was set to 0. As expected, the 
results indicated that the common factor model matching the generating population 
was favoured ≥99% of the time across the model fit indices (Supplementary Fig. 37).
Simulation of partial sample overlap. To examine the effect of sample overlap on 
estimates obtained from genomic SEM, the GCTA package3 was used to generate a 
50% heritable, quantitative phenotype with 30,000 causal SNPs. The phenotype was 
paired with genetic data from 100,000 randomly selected, unrelated individuals 
of European descent from UKB data for 1,209,498 HapMap3 SNPs. Three sets 
of 60,000 participants each were created using this same phenotype, with 40,000 
participants overlapping across all 3 identical phenotypes and 20,000 participants 
unique to each phenotype (that is, 100,000 total participants). These three 
subsamples were individually analysed in PLINK56 to produce univariate GWAS 
summary statistics. The multivariable LDSC function was then used to construct 
the genetic covariance and sampling covariance matrix using the three sets of 
summary statistics, and genomic SEM was used to fit a one-factor model with the 
SNP predicting the common factor. Two key results were verified at this stage. 
First, we confirmed that the standardized factor loadings on the common factor 
were 1 for the identical phenotypes. Second, we verified that the bivariate linkage 
disequilibrium score intercepts used to account for sample overlap in the sampling 
covariance matrix were as expected. The equation for the linkage disequilibrium 
score bivariate intercept is4: Nsρ/√(N1N2), where Ns is the sample overlap, ρ is the 
phenotypic correlation, N1 is the sample size of trait 1, and N2 is the sample size 
of trait 2. In this simulation, we observed bivariate intercepts of 0.67, which is as 
expected given sample overlap of 40,000, a phenotypic correlation of 1 and sample 
sizes of 60,000 (that is, 40,000 × 1/√(60,000 × 60,000) = 0.67). Finally, estimates 
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from this multivariate GWAS were compared with estimates from the univariate 
GWAS in PLINK for the full set of 100,000 participants. If sample overlap is not 
appropriately accounted for in this example, such that data are incorrectly treated 
as deriving from 180,000 participants (as opposed to 100,000 total participants), 
we would expect the Z statistics for the SNP effects from genomic SEM to be 
upwardly biased relative to those from a univariate GWAS applied directly to the 
single phenotype in the 100,000 participants. We observed no such bias. A linear 
regression of Z statistics from genomic SEM (from the 3 overlapping samples 
of 60,000 participants each) predicting univariate GWAS Z statistics in the 
complete sample (of 100,000 participants) revealed near-perfect correspondence 
(unstandardized slope = 1.003; intercept = −0.003).
MTAG simulation. To evaluate the relationship between estimates from MTAG 
and those from a genomic SEM formulation of the MTAG model, we specified a 
bivariate system of heritable phenotypes, A and u. Phenotype A was constructed 
using the GCTA package3, and specified to be 60% heritable and affected by 
a random selection of 30,000 HapMap3 SNPs. Phenotype u was constructed 
separately using the GCTA package, and also specified to be 60% heritable and 
affected by a different random selection of 30,000 HapMap3 SNPs. Both A and u 
were standardized (M = 0; s.d. = 1). Phenotype B was constructed from phenotypes 
A and u according to the equation B = 0.7 A + 0.7 u. This procedure resulted 
in 60% heritabilities for both traits A and B, with a genetic correlation of 0.7 
between them. Sample sizes for phenotypes A and B were 25,000 each, with 10,000 
participants contributing data for both phenotypes A and B (that is, 40% sample 
overlap), such that the analytic dataset was composed of 40,000 unique individuals 
in total. Both MTAG11 and a genomic SEM model specified to satisfy the same 
moment conditions as MTAG (see Supplementary Methods) were then each run 
with trait A as the supporting phenotype used to boost the power for target trait 
B, and estimates from MTAG and genomic SEM specified to satisfy the MTAG 
moment conditions were compared. Results indicated near-perfect correspondence 
from a linear regression in which Z statistics from MTAG were used to predict 
those from a genomic SEM specified to satisfy the MTAG moment conditions 
(Supplementary Fig. 20; unstandardized slope = 0.999; intercept = 2.65 × 10−4).
Quality control procedures. LD-score regression. For the p-factor, neuroticism 
and anthropometric traits, quality control procedures for producing the S and 
VS matrix followed the defaults in LDSC. We recommend using these defaults 
for multivariable LDSC, including removing SNPs with MAF < 1%, information 
scores < 0.9, SNPs from the major histocompatibility complex (MHC) region, 
and filtering SNPs to HapMap3. Quality control procedures for the multivariable 
regression example mirrored those used by Nieuwboer et al.23 for comparative 
purposes. More specifically, SNPs were excluded with MAFs < 0.05, as determined 
by the HapMap Consortium57, and with information values less than 0.9 or greater 
than 1.1. SNPs were also filtered to HapMap3. The linkage disequilibrium scores 
used for the analyses presented were estimated from 1000 Genomes Phase 3, but 
restricted to HapMap3 SNPs.
Multivariate GWASs. Summary statistics are only restricted to HapMap3 SNPs for 
the estimation of the genetic covariance and sampling covariance matrix in linkage 
disequilibrium score regression, whereas all SNPs passing quality control filters are 
included for multivariate GWASs. To obtain summary statistics for multivariate 
GWASs, we recommend using quality control procedures including the removal of 
SNPs with MAF < 0.01 in the reference panel, and those SNPs with an imputation 
information (INFO) score < 0.6. MAFs were obtained for the current analyses 
using the 1000 Genomes Phase 3 reference panel. Using these quality control 
steps, 1,979,881 SNPs were present across schizophrenia, bipolar disorder, MDD, 
PTSD and anxiety. For neuroticism, there were 7,265,104 SNPs that were present 
across all phenotypes. These quality control procedures are the defaults for the 
processing function within the GenomicSEM package. The regression effects for 
the univariate indicators of the p factor were standardized using the procedure 
for logistic coefficients outlined above. Regression effects for neuroticism 
indicators were converted from linear probability to logistic coefficients and then 
standardized with respect to the variance in the outcome.
Out-of-sample prediction. p factor. Genomic SEM analyses that were used 
to produce the summary statistics for construction of PGSs for out-of-sample 
prediction omit the Psychiatric Genetics Consortium (PGC) MDD 2018 GWAS 
and schizophrenia 2018 GWAS and replace them with the PGC MDD 2013  
(ref. 58) and PGC schizophrenia 2014 (ref. 59) GWASs to prevent overlap between 
discovery and target samples. This resulted in a genomic SEM-based multivariate 
GWAS using 930,581 SNPs. Analyses used to construct a phenotypic p factor 
for polygenic prediction in the UKB dataset were restricted to data on up to 
N = 332,050 European participants. The genomic SEM of the p factor employed 
case-control GWAS statistics to construct summary statistics for a general factor of 
liability for clinically severe levels of psychopathology as the discovery phenotype. 
For out-of-sample prediction, we selected a set of psychiatric symptoms (rather 
than diagnoses) to construct liability for general and domain-specific factors 
of psychiatric symptomology across the subclinical-to-clinical ranges as the 
target phenotypes. From the UKB dataset, we chose symptoms falling within the 
following domains: psychosis, mania, depression, post-traumatic stress and anxiety. 
We fit a confirmatory factor model (diagram shown in Supplementary Fig. 29) 
to the phenotypic symptom endorsements, treating them as ordered categorical 
variables. Analyses were run in Mplus60, with the target phenotypes—the p factor 
and each of the individual domains—specified as latent variables. PGS variables 
were specified to directly predict the latent phenotypes within the model (that is, 
factor score estimates were not used). To construct PGSs, we removed from both 
the p-factor and univariate summary statistics the 5 SNPs that were identified 
as having genome-wide significant QSNP estimates for maximum likelihood, 
along with SNPs that were in linkage disequilibrium with these SNPs using an r2 
threshold of 0.1 and a 500-kb window. PGSs were constructed using PRSice61, with 
linkage disequilibrium clumping set to r2 > 0.25 over 250-kb sliding windows. PGSs 
for the p factor were based on the WLS summary statistics produced using genomic 
SEM. We ran PGS analyses using a P-value threshold of 1.0 (that is, we used all 
available SNPs apart from those removed due to QSNP analyses). To maintain 
comparability, PGSs for the univariate summary statistics were constructed based 
on the same SNPs with which the PGSs for the p factor were constructed. In the 
confirmatory factor models, we included controls for age, sex, genotyping array 
and 40 principal components of ancestry in conjunction with the PGS predictor.
Neuroticism. The raw total on the 12-item neuroticism subtest of the Eysenck 
Personality Questionnaire-Revised62 (maximum score = 12) was used as the target 
phenotype for out-of-sample prediction. Both genetic and neuroticism target data 
were available on 19,876 European participants in the Generation Scotland cohort63. 
Neuroticism scores were residualized for age, sex and 20 principal components of 
ancestry before examining out-of-sample prediction. PGSs were constructed using 
PRSice61, with linkage disequilibrium clumping set to r2 > 0.25 over 250-kb sliding 
windows and using a P-value threshold of 1.0. PGSs for neuroticism were based on 
the WLS summary statistics produced using genomic SEM. Regression analyses 
were run using the lmekin function within the coxme package in R with a random 
intercept to account for nesting of individuals within families.
Clumping and biological annotation. Lead SNPs for univariate indicators and 
the common factors were identified using the clumping algorithm in PLINK56. 
We defined linkage disequilibrium-independent SNPs using an r2 threshold of 0.1 
and a 500-kb window using the same 1000 Genomes Phase 3 reference panel used 
for obtaining MAF. For chromosomes 6 and 8, an additional pruning filter was 
used of 1 Mb and r2 > 0.1 to account for long-range linkage disequilibrium due to 
the MHC region and pericentric inversion, respectively. Increasing the pruning 
window further to 4 Mb did not influence our findings on chromosome 6 or 8. The 
lead SNPs identified using PLINK were entered into DEPICT. Prioritized genes, 
enriched gene sets and enriched tissues were identified using the standard false 
discovery rate of 5%.
Description of genomic SEM software. The genomic SEM software package, 
GenomicSEM, is written as an R package and is available through GitHub at 
https://github.com/MichelNivard/GenomicSEM. GenomicSEM contains several 
functions, including procedures for QCing and standardizing summary statistics, 
a function for producing genetic covariance matrices (SLDSC) and their associated 
sampling covariance matrices (VSLDSC) using a multivariable extension of linkage 
disequilibrium score regression, functions for fitting genomic structural equation 
models to SLDSC and VSLDSC, and functions for adding SNP-level data to the SLDSC 
and VSLDSC matrices (referred to as SFull and VSFull) that are used for implementing 
genomic SEM for multivariate GWAS discovery. Functions include both pre-
specified models (for example, a single common factor model) and user-specified 
models. Output includes both unstandardized and standardized solutions, 
along with the fit indices described above. WLS estimation is the default in 
the GenomicSEM package. GenomicSEM uses the lavaan Structural Equation 
Modeling package64 as the primary workhorse for model specification and 
numerical optimization. We also provide limited support for OpenMx65. To run 
the multivariable LDSC function on 5 phenotypes takes ~15 min—a step in the 
analyses that only needs to be performed once. For models of multivariate genetic 
architecture that do not incorporate individual SNP effects, the typical run time 
observed for 3–15 traits is <1 s on a standard personal computer. Using parallel 
processing implemented in the GenomicSEM package on a 4-core/8-thread laptop, 
a multivariate genomic SEM GWAS with 5 indicators and ~1 million SNPs took 
~8 h. The time needed to run the models will increase with increasing model 
complexity, and with increasing numbers of variables or SNPs. In these cases, the 
computing time can be greatly reduced by using a computing cluster to distribute 
SNP models across nodes/cores.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are all publicly available. Links  
to the location of summary statistics, linkage disequilibrium scores, reference  
panel data and the code used to produce the current results can all be found at 
https://github.com/MichelNivard/GenomicSEM/wiki.
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Code availability
GenomicSEM software is an R package that is available from GitHub at  
https://github.com/MichelNivard/GenomicSEM. The GenomicSEM R package 
can be installed directly at https://github.com/MichelNivard/GenomicSEM/wiki. 
Example GenomicSEM code, including code used to produce the results, is provided 
for each set of analyses at https://github.com/MichelNivard/GenomicSEM/wiki.
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Software and code
Policy information about availability of computer code
Data collection No software was used for data collection. 
Data analysis Lead SNPs and GWAS for simulation studies were conducted using PLINK v1.9.  
Simulation of phenotypes with corresponding genotypes was conducting using GCTA v1.91.  
The construction of polygenic scores for out-of-sample prediction was conducted using PRSice  v1.25.  
Genomic SEM was run using code we make available for download at https://github.com/MichelNivard/GenomicSEM
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For construction of the p-factor, summary statistics for PTSD, Anxiety, Bipolar Disorder, and Major Depressive Disorder were downloaded from: http://
www.med.unc.edu/pgc/results-and-downloads. Summary statistics for Schizophrenia were downloaded from: http://walters.psycm.cf.ac.uk/.  
 
The GWIS summary statistics for Bipolar Disorder and Schizophrenia were also downloaded from the cross-disorder section of the PGC website. The summary 
statistics for educational achievement are available for download from: https://www.thessgac.org/data.  
 
Summary statistics for item-level indicators of neuroticism were downloaded from: https://docs.google.com/spreadsheets/d/1b3oGI2lUt57BcuHttWaZotQcI0-
mBRPyZihz87Ms_No/edit#gid=1209628142. We use Round 1 of the Neale's Lab UKB GWAS results.  
 
Summary statistics for early-life traits used in the factor model of anthropometric traits (birth length, birth weight, infant head circumference, childhood obesity) 
were obtained from: https://egg-consortium.org/.  
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Behavioural & social sciences study design
All studies must disclose on these points even when the disclosure is negative.
Study description Our study uses publically available summary statistics to examine a new developed method, Genomic SEM. Genomic SEM can be used to 
examine any form of structural equation model (e.g., factor analysis, mediation, etc.) using summary statistics. The software provides 
model fit statistics, and can also be used to produce summary statistics for a latent trait. 
Research sample We use only publically available summary statistics for our analyses. As Genomic SEM relies on ld-score regression (LDSC) to construct 
genetic covariance matrices, and LDSC requires summary statistics to be within a single ethnic population due to differences in linkage 
disequilibrium across populations, we use only summary statistics restricted to European populations. 
Sampling strategy This is not applicable as we use previously collected data. 
Data collection This is not applicable as we use previously collected data. 
Timing This is not applicable as we use previously collected data. 
Data exclusions We use only summary statistics from European populations due to the requirements of LDSC, as noted above. 
Non-participation This is not applicable as we use previously collected data. 
Randomization This is not applicable as we use previously collected data. 
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Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
